Peak Pharmaceuticals, Inc. Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended June 30, 2015
For the nine months, the company reported revenues of $751,313. Net loss was $1,893,779 against $2,492,464 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.75 USD | -6.25% | -6.25% | +116.76% |
1st Jan change | Capi. | |
---|---|---|
+116.76% | 78.47M | |
+10.66% | 3,092B | |
+9.13% | 86.07B | |
+5.43% | 78.64B | |
-16.13% | 53.11B | |
+28.71% | 49.21B | |
+31.31% | 46.21B | |
-33.61% | 41.11B | |
+73.04% | 40.25B | |
+3.06% | 28.44B |